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Abstract
Background: We proposed a non-parametric method, named Non-Parametric Change Point Statistic (NPCPS for short), by
using a single equation for detecting differential gene expression (DGE) in microarray data. NPCPS is based on the change
point theory to provide effective DGE detecting ability.
Methodology: NPCPS used the data distribution of the normal samples as input, and detects DGE in the cancer samples by
locating the change point of gene expression profile. An estimate of the change point position generated by NPCPS enables
the identification of the samples containing DGE. Monte Carlo simulation and ROC study were applied to examine the
detecting accuracy of NPCPS, and the experiment on real microarray data of breast cancer was carried out to compare
NPCPS with other methods.
Conclusions: Simulation study indicated that NPCPS was more effective for detecting DGE in cancer subset compared with
five parametric methods and one non-parametric method. When there were more than 8 cancer samples containing DGE,
the type I error of NPCPS was below 0.01. Experiment results showed both good accuracy and reliability of NPCPS. Out of
the 30 top genes ranked by using NPCPS, 16 genes were reported as relevant to cancer. Correlations between the detecting
result of NPCPS and the compared methods were less than 0.05, while between the other methods the values were from
0.20 to 0.84. This indicates that NPCPS is working on different features and thus provides DGE identification from a distinct
perspective comparing with the other mean or median based methods.
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Introduction
When normal gene expression is exposed to radiation, virus
infection, etc., it would cause gene mutation or gene abnormal
activation, which probably leads to cancer arising [1]. There are
observable differences between cancer and normal tissues in their
expression values on single-gene level, which enables recognition
of cancer-related gene from a statistical perspective.
Based on microarray gene expression profiling [2], many
methods were reported aiming to detect such difference in gene
expression, or normally called differential gene expression (DGE)
[3,4]. Among these methods, T-statistics is a classical and widely-
used DGE detecting methods, which works on the hypothesis that
all the cancer samples are over-expressed compared with the
normal samples [5]. Other work has also presented meaningful
results, such as empirical Bayes approach [6] (Efron 2001),
mixture model approach [7] (Pan, 2003), and SAM [8] (Storey
2003). However, considering the heterogeneity of gene activation,
it is reasonable to assume that DGE could only take place in a
subset of cancer samples. Many methods were proposed to solve
DGE detection under this assumption, such as PPST (permutation
percentile separability test) [9] (Lyons-Weiler, 2004), COPA
(cancer outlier profile analysis) [10,11], OS (outlier sum) [12]
(Tibshirani, 2007), ORT (outlier robust t-statistics) [13] (Wu,
2007), and MOST (maximum ordered subset t-statistics) [14]
(Lian, 2008).
Most of the aforementioned methods attempt to identify the
abnormal data points based on the overall percentile of the gene
expression profile. However, it is reasonable to assume that the
DGE detection could be achieved by searching for the change
point of the gene expression profile If we consider the single-gene
expression profile as a data sequence, for non-DGE sequence,
there is no significant change between the data distributions of
normal and cancer samples; for DGE sequence, since the gene
expression is over regulated in cancer group, the data distribution
of cancer and normal samples become distinctly different, which
would result in a significant change point in the sequence of gene
expression profiles.
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such as atmospheric and financial analysis. There are also
applications of change-point theory to the microarray analysis,
for example, a change point detection model for genomic
sequences of continuous measurements [16], ARTIVA formalism
for topology inference of regulatory network [17], a Bayesian
model for DGE patterns of the DosR regulon of Mycobacterium
tuberculosis in the timing of gene induction [18]. With respect to
DGE analysis, there are BRIDGE (Bayesian robust inference for
differential gene expression) for DGE detection in microarrays
with small sample sizes [19], and DGE detecting method LRS
(likelihood ratio test) [20] (Hu, 2008).
Since a few of the currently available change-point methods
deal explicitly with estimation of the number and location of
change points, and moreover these methods may be somewhat
vulnerable to deviations of model assumptions usually employed
[16], we propose a non-parametric statistical method for DGE
detection, named as NPCPS (Non-Parametric Change Point
Statistics). NPCPS is based on modified Kolmogorov statistic to
detect the single-change point in a data sequence [21]. This
method compares the data distribution of normal and cancer
group to detect the existence of possible change-point in the cancer
group, and to estimate the position of change-points. Besides, as a
non-parametric inferential method, NPCPS does not make
assumptions about the probability distributions of the variables
being assessed, and accordingly, it is not necessary to normalize
the microarray data before calculating the test statistic like other
parametric methods usually do. As comparison, we tested several
percentile-based methods and LRS. BRIDGE was not included as
it is originally designed for two-sample problem and application to
larger sample size is computationally heavy. NPCPS works
comfortably with large-scale dataset, and both simulation and
experiment results show that NPCPS is effective for DGE
detection.
Methods
Suppose X~x1,:::,xr,:::,xn are independent random variables
with cumulative distribution function F, and r is the change point
of X. Then, for distribution function Fr of Xr~x1,:::,xr and Fn{r
of Xn{r~xrz1,:::,xn, there exists a value x0 that satisfies
Fr(x0)=Fn{r(x0),x0 [ ½x1,xn . Otherwise, if r is not the change
point, we have F(x0)~Fr(x0)~Fn{r(x0),x0 [ ½x1,xn . The
change point is also noted as
Table 1. FPR of NPCPS in Monte Carlo simulation.
n1=n 2=25, a=0.05, C(a)=1.358
k 13 5 7 9 1 2 1 5 2 0 2 5
FPR 0.5953 0.1524 0.0333 0.0054 0.0007 0.0001 0.0 0.0 0.0
n1=n 2=25, a=0.01, C(a)=1.628
k 1 357 9 1 2 1 5 2 0 2 5
FPR 0.84 0.48 0.163 0.04 0.008 0.002 0.0 0.0 0.0
n1=n 2=50, a=0.05, C(a)=1.358
k 1 4 7 9 12 17 22 30 50
FPR 0.5263 0.0541 0.0040 0.0006 0.0 0.0 0.0 0.0 0.0
n1=n 2=50, a=0.01, C(a)=1.628
k 1 4 7 9 12 17 22 30 50
FPR 0.802 0.268 0.042 0.009 0.0 0.0 0.0 0.0 0.0
doi:10.1371/journal.pone.0020060.t001
Table 2. Actual and average estimate of change point using NPCPS in Monte Carlo simulation.
n1=n 2=25, a=0.01, C(a)=1.628
k 135791 2 1 5 2 0 2 5
t0 0.98 0.94 0.90 0.86 0.82 0.76 0.70 0.60 0.50
^ t t0 0.6 0.80 0.84 0.82 0.81 0.74 0.689 0.597 0.505
n1=n 2=50, a=0.01, C(a)=1.628
k 1 4 7 9 12 17 22 30 50
t0 0.99 0.96 0.93 0.91 0.88 0.83 0.78 0.65 0.50
^ t t0 0.623 0.880 0.898 0.89 0.868 0.824 0.775 0.650 0.505
t0: Actual change point. ^ t t0: Average estimate of change point.
doi:10.1371/journal.pone.0020060.t002
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Gene expression profile of a single gene could also be
considered as a sequence of independent variables as below:
X1~x1,:::,xn1,
X2~x1,:::,xn2,
X~X1zX2~x1,:::,xn1,:::,xn,n~n1zn2:
ð2Þ
Here, X1 contains expression values of normal samples in known
distribution function F1(x), and X2 contains expression values of
disease samples. Over or under expression values in X2 would
result in a change point in X.
To detect the change point, in the hypothesis test we used a
modified Kolmogorov statistic (K-statistic), which evaluates the
distance between two distribution functions:
Dnk(x)D
n{k
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n{k
p (F
_
(n{k)(x){F1(x)),k~0,1,:::,n{1, ð3Þ
F
_
n{k(x) is the empirical distribution function of Xn{k,:::,Xn,
defined as:
F
_
n{k(x)D
1
n{k
X n
i~kz1
I(Xiƒx),k~0,1,:::,n{1, ð4Þ
where I is an indicator function. F{1
1 (y) is the inverse function of
F1(x) defined as
F{1
1 (y)Dinffx : F1(x)§yg,0vyv1, ð5Þ
where y is a variable increasing with a fixed step that is subject to
user’s selection (we selected 100 in the simulation study and
experiment).
Therefore, the testing procedure is defined as
Dn(t,y)D
1
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n{½nt 
p
X n
i~½nt z1
fI(XiƒF{1
1 (y)){yg,
0vtv1,0vyv1,
ð6Þ
where ½:  means round toward negative infinity.
Null hypothesis H0 is true when sup
0vtv1
sup
0vyv1
Dn(t,y) jj vC(a),
i.e. no change point detected; alternative hypothesis H1 is true
when sup
0vtv1
sup
0vyv1
Dn(t,y) jj §C(a), i.e. X has a change point. C(a)
is the critical value and a is the significance level. Typical values of
C(a) include C(0.05)=1.358 and C(0.05)=1.628.
To give an estimate of change point, we define
Dn(t)D sup
0vyv1
Dn(t,y) jj , ð7Þ
and
DnD sup
0vtv1
Dn(t) jj : ð8Þ
Let ^ t t0(n) be the estimate of t0, which is defined as:
t
^
0
(n)Dinfft : Dn(t)~Dng: ð9Þ
Since the test statistic measures the difference between two
distribution functions, larger Dn(t,y) jj indicates more significant
DGE, while the positive Dn(t,y) corresponds to under-expression
and the negative Dn(t,y) corresponds to over-expression, respec-
tively.
Results and Discussion
Methods compared with NPCPS
Gene expression profile obtained from microarray data is often
considered as a g6n matrix, which contains g rows of genes with
their expression levels in n samples, in which normal group has n1
samples, and disease group has n2 samples. Let xij be the expression
intensity of the ith gene in the jth sample of the normal group,
while i=1 ,2 ,… ,g, j=1 ,2 ,… ,n1; let yij be the expression intensity
of the ith gene in the jth sample of the disease group, while i=1,2,
Figure 1. FPR and estimate of change-point position. (A) Monte
Carlo simulation results of dataset with size n1=n 2=25 and significance
level a=0.01. (B) Monte Carlo simulation results of dataset with size
n1=n 2=50 and significance level a=0.01. The x-axis is k, the number of
samples in simulated dataset that contained DGE. The trend of curves in
(A) and (B) was similar. Both FPR and estimate of change-point
enhanced with the increasing k. When k.9, the difference between the
true change-point and the estimated change-point was very small, and
the FPR of NPCPS became lower than the significance level a, which
indicated that the hypothesis test of NPCPS passed the Monte Carlo
simulation.
doi:10.1371/journal.pone.0020060.g001
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medi~median xij
  
1ƒjƒn1
, yij
  
1ƒjƒn2
  
, ð10Þ
Define medix, the normal-group median of the ith gene, and mediy
the cancer-group median as
medix~median1ƒjƒn
1 xij
  
, ð11Þ
mediy~median1ƒjƒn
2(yij): ð12Þ
Parametric methods for DGE in cancer subset. There
have been many parametric methods proposed based on the
mean, median and median absolute deviation (MAD) of the gene
expression profile, and following are some typical methods.
COPA [10,11]: COPA first normalizes the expression data
using the group mean and MAD to prevent impact to the data
distribution hypothesis by outliers, then sorts the expression value
and detects cancer genes though the rth percentile of the cancer
group. If the MAD of the ith gene is approximated as
madi~
1:4826|median xij{medi
  
1ƒjƒ1
, yij{medi
  
1ƒjƒn2
  
:
ð13Þ
The COPA statistic is defined as
copai~
qr(fyijg1ƒjƒn2){medi
madi
, ð14Þ
where qr(i) is the rth percentile of the ith gene expression values,
which is subject to the user’s selection.
OS [12]: OS introduced heuristic rule as an additional function,
and also applied the percentile knowledge to detect DGE. OS
normalizes every gene to ensure the same data scale, which is
convenient for gene comparison. In OS, gene expression values
greater than Q3(i)+IQR(i) and smaller than Q1(i)2IQR(i) are
statistically considered as DGE. The OS statistic is defined as
below.
Figure 2. Selected ROC curves of normal dataset with m=2.(A) n1=n 2=25, k=3. (B) n1=n 2=25, k=5. (C) n1=n 2=25, k=9. (D) n1=n 2=50,
k=1. (E) n1=n 2=50, k=4. (F) n1=n 2=50, k=9. The x-axis is FPR, and the y-axis is TPR. The significance level a=0.01 for NPCPS. Larger area under
ROC curves indicates better sensitivity and specificity. An ROC curve along the diagonal line indicates random-guess.
doi:10.1371/journal.pone.0020060.g002
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qr(fyijg1ƒjƒn2){medi
madi
ð15Þ
The group with over expression is defined as
Wi~
Xn2
j~1 yijIfyijwq75(i)zIQR(i)gð 16Þ
Similarly, the group with under expression DGE is defined as
Wi~
Xn2
j~1 yijIfyijvq25(i){IQR(i)gð 17Þ
ORT [13]: Compared with OS, ORT is similar but uses
the median of the normal group instead of the median of all
data, and estimates the absolute error using the median of
several groups instead of the square error as in COPA [11].
T h ep u r p o s eo ft h e s ec h a n g e si st oa c q u i r em o r er o b u s ta n d
consistent estimation. Accordingly, the estimate MAD in ORT
is
madij~
1:4286|medianf xij{medix
       
1ƒjƒn1
,y ij{mediy
       
1ƒjƒn2
g
ð18Þ
The ORT statistic is
ortj~
P
i [ Cj(fyijg1ƒjƒn2{medix)
madij
, ð19Þ
where Ci is the cancer group of the ith gene. For over
expression,
Ci~
Xn2
j~1 yijIfyijwq75(fxijg1ƒjƒn1)zIQR(fxijg1ƒjƒn
1
)g: ð20Þ
Figure 3. Selected ROC curves of normal dataset with m=1.(A) n1=n 2=25, k=6. (B) n1=n 2=25, k=9. (C) n1=n 2=25, k=14. (D) n1=n 2=50,
k=6. (E) n1=n 2=50, k=9. (F) n1=n 2=50, k=15. The x-axis is FPR, and the y-axis is TPR. The significance level a=0.01 for NPCPS. Larger area under
ROC curves indicates better sensitivity and specificity. An ROC curve along the diagonal line indicates random-guess.
doi:10.1371/journal.pone.0020060.g003
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PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e20060Figure 4. Selected ROC curves of skew-normal dataset. (A) n1=n 2=25, mu=2, k=3. (B) n1=n 2=25, mu=2, k=5. (C) n1=n 2=25, mu=2, k=9.
(D) n1=n 2=50, mu=2, k=4. (E) n1=n 2=50, mu=2, k=9. (F) n1=n 2=25, mu=1, k=6. (G) n1=n 2=25, mu=1, k=9. (H) n1=n 2=50, mu=1, k=9. (I)
n1=n 2=50, mu=1, k=14.The x-axis is FPR, and the y-axis is TPR. The significance level a=0.01 for NPCPS. Larger area under ROC curves indicates
better sensitivity and specificity. An ROC curve along the diagonal line indicates random-guess.
doi:10.1371/journal.pone.0020060.g004
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Ci~
Xn2
j~1 yijIfyijvq25(fxijg1ƒjƒn1){IQR(fxijg1ƒjƒn1)g:
ð21Þ
MOST [14]: Gene with expression value greater than MOSTik
is considered as a differential gene expression. The testing statistic
MOSTik is defined as:
MOSTik~ max
1ƒkƒn1
(
P
1ƒjƒk (yij{median(fxijg1ƒjƒn0))
1:4826|median(X
0
i |Y
0
i )
): ð22Þ
When k is unknown, the data are normalized firstly by mk and s
2
k,
and the MOSTik is defined as
MOSTik
~ max
1ƒkƒn1
(
P
1ƒjƒk (yij{median (fxijg1ƒjƒn0))
1:4826|median (X
0
i |Y
0
i )
{mk)=sk:
ð23Þ
Non-parametric methods for DGE in cancer subset. PPST
[9]: As a non-parametric method, PPST compares the expression
levels of thousands of genes in two sample groups, i.e. the control
group (A) and the case group (B). The detection focuses on genes in
group A of which the expression levels are higher than a certain
percentile of group B’s expression values (A.B), which is a type I
error in statistics, and vice versa (B.A). There are two marks for each
gene, s1 and s2. S1 is the number of samples in group A that are
higher than the 95% of group B added by the number of samples in
group B that are lower than the 95% of group A. S2 is defined as the
opposite to s1. Considering a given gene, if the expression value in
group A is higher than the 95th percentile of group B, it is considered
as over expression; if the expression value is lower than that in group
B, it is considered as under expression. Define the PPST statistic of
each gene with over expression as:
ppsti~
Xm
i~1 yijIfZi,yijwq95(xi1,:::,xin)gð 24Þ
PPST statistic of gene with under expression can be obtained
similarly.
LRS [15]: in LRS, cancer outlier samples are viewed as coming
from a distribution with higher mean expression intensity than all
the normal and other cancer samples. The purpose of LRS is to
test such unequal mean. For up-regulation, LRS first organizes all
the samples so the non-cancer samples are arranged before the
cancer samples, and the cancer samples are sorted by their
expression intensities in the ascending order. Sn is the summation
of the expression intensities of all the samples and the LRS statistic
is as follows,
l~ max
m0ƒiƒm1
iSn=n{Si
½i(1{i=n) 
1=2 ,n1z1ƒm0vm1vn: ð25Þ
Traditional methods for DGE in entire cancer group. T-
statistic [5]: this traditional method assumes that the cancer
sample group is generally over or under-expressed compared with
the normal samples. The t-statistic is defined as:
Ti~
yi{xi
si
ð26Þ
where xi is the sample mean of normal group expression values and
yi is the sample mean of cancer group expression values, Si is the es-
timate of combined standard deviation. Differentially expressed genes
are recognized when the testing statistic exceeds a certain threshold.
Monte Carlo simulation
Monte Carlo simulation can be used to evaluate the per-
formance of a hypothesis test in terms of the ratio of Type I error,
i.e. false positive rate (FPR). For each Monte Carlo simulation,
NPCPS was applied to an artificial 7000-gene dataset (normal
random numbers with mean=0, standard deviation sd=1)
composed of n1 normal samples and n2 cancer samples, of which
k (0,k,n2) cancer samples contained DGE simulated by adding a
Table 3. AUC of ROC curves of the simulation on data in
normal distribution.
Data
Parameter AUC
n mu k NPCPS LRS COPA OS ORT PPST T MOST
50 2 3 0.79 0.82 0.72 0.75 0.76 0.69 0.68 0.67
50 2 5 0.90 0.92 0.82 0.80 0.85 0.79 0.79 0.76
50 2 9 0.96 0.97 0.87 0.81 0.92 0.91 0.91 0.89
100 2 1 0.52 0.57 0.53 0.28 0.58 0.54 0.53 0.52
100 2 4 0.85 0.84 0.72 0.81 0.82 0.69 0.69 0.67
100 2 9 0.96 0.96 0.88 0.90 0.92 0.85 0.86 0.84
50 1 6 0.73 0.74 0.63 0.58 0.65 0.68 0.72 0.67
50 1 9 0.82 0.81 0.67 0.61 0.72 0.76 0.79 0.74
50 1 14 0.90 0.89 0.73 0.65 0.80 0.87 0.90 0.87
100 1 6 0.71 0.70 0.60 0.59 0.59 0.66 0.65 0.63
100 1 9 0.79 0.76 0.66 0.64 0.69 0.66 0.70 0.67
100 1 15 0.88 0.85 0.70 0.66 0.75 0.78 0.82 0.80
doi:10.1371/journal.pone.0020060.t003
Table 4. AUC of ROC curves of the simulation on data in
skew-normal distribution.
Data
Parameter AUC
n mu k NPCPS LRS COPA OS ORT PPST T MOST
50 2 3 0.73 0.69 0.58 0.57 0.65 0.62 0.64 0.61
50 2 5 0.87 0.80 0.61 0.59 0.69 0.69 0.75 0.71
50 2 9 0.95 0.91 0.66 0.59 0.80 0.82 0.90 0.83
100 2 4 0.78 0.71 0.58 0.58 0.63 0.63 0.66 0.63
100 2 9 0.95 0.85 0.64 0.64 0.74 0.72 0.80 0.75
50 1 6 0.66 0.60 0.54 0.55 0.59 0.63 0.66 0.63
50 1 9 0.75 0.70 0.60 0.56 0.63 0.70 0.76 0.71
100 1 9 0.72 0.64 0.57 0.57 0.62 0.63 0.70 0.67
100 1 14 0.82 0.71 0.60 0.58 0.66 0.69 0.78 0.73
doi:10.1371/journal.pone.0020060.t004
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(B) CP-position distribution of 989 genes with negative Dn,21.628.
doi:10.1371/journal.pone.0020060.g005
Table 5. Results and description of top-ranked genes with positive test statistic Dn.
NPCPS Ranking Dn CP Position Gene Name Description
1 2.91 27 PDE4B The phosphodiesterase PDE4B limits cAMP-associated PI3K/
AKT-dependent apoptosis in diffuse large B-cell lymphoma.
2 2.80 34 N/A
3 2.79 32 N/A
4 2.74 27 SCARB2
5 2.74 27 C9 Upregulation of plasma C9 protein in gastric cancer
patients.
6 2.73 22 RAB2A
7 2.73 27 MEF2A
8 2.69 37 N/A
9 2.66 19 ITK ITK-SYK causes a T-cell lymphoproliferative disease in mice,
supporting its role in T-cell lymphoma development in
humans.
10 2.66 41 TCF3 Misregulation plays a role in disease such as cancer, where
overactive Wnt signaling drives LEF/TCFs to transform cells
11 2.64 31 JAG1 Heterogeneity of Jagged1 expression in human and mouse
intestinal tumors: implications for targeting Notch signaling
12 2.64 16 HMGA2 LEF/TCFs to transform cells
13 2.62 28 NEFL
14 2.60 16 IL2 The development of breast tumor is associated with an
increased expression of IL-2 and this expression also seems
to be associated with the malignancy of the tumor.
15 2.60 26 RARRES1 RARRES1 expression is significantly related to tumor
differentiation and staging in colorectal adenocarcinoma
16 2.60 15 PRKCB Target for inhibiting gastric cancer cell invasion
17 2.58 14 PRPS2
18 2.56 19 IFNA10
doi:10.1371/journal.pone.0020060.t005
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simulations were carried out according to different values of
sample size n, DGE sample size k, and significance level a. The
FPR (Table 1) and average estimate of change point (Table 2)
were computed and the results of simulation with a=0.01 were
illustrated in Fig. 1. For data set n1=n2=25 (Fig. 1A), the FPR was
larger when k was smaller; FPR decreased with k increasing;
when k was equal to or larger than 9, the detecting accuracy of
NPCPS was sufficient to satisfy the significance level. For data set
n1=n2=50 (Fig. 1B), k should be not less than 9 to satisfy the
significance level. The estimate of change point enhanced greatly
when k increased; the estimated position became very close to the
actual position at the same time as the FPR dropped below the
significance level. This indicates that NPCPS is highly sensitive to
left boundary and less sensitive to the right boundary, when the F2
information is not sufficient [21].
ROC analysis on simulated data
First, we test NPCPS (a=0.01) and seven other methods,
namely COPA, ORT, OS, MOST, T, LRS, and PPST, on
normally distributed datasets (mean=0, sd=1) with different m, n
and k. When k was getting greater, all methods produced better
ROC (Fig. 2 and Fig. 3). For m=2, when n=50 (Fig. 2A–2C),
NPCPS was slightly weaker than LRS, and better than the other
methods; when n=100 (Fig. 2D–2E), NPCPS was very similar
to LRS, and better than the other methods. For m=1, NPCPS
gave the best performance for both n=50 and n=100 datasets and
different values of k (Fig. 3A–3F). This indicated that NPCPS had
better sensitivity for less significant DGE compared with the other
seven methods. Among the non-parametric method, PPST was
not significantly better than the parametric methods, while LRS
and NPCPS were continuously better than the other methods.
This indicated that methods based on change-point were more
effective and robust than methods based on percentile and MAD.
Second, we tested NPCPS (a=0.01) and other seven methods
on datasets generated from skew-normal (SN) distribution (Fig. 4).
For different n and k, NPCPS had significantly larger area under
the ROC curves compared with the other methods. By comparing
Fig. 2 and Fig. 4 we can see that NPCPS was both effective
for normal and skew-normal data distribution, and when k=9
gave similarly good ROC (Fig. 2C compared with Fig. 4C, Fig. 2F
compared with Fig. 4E). The other seven methods, including
Table 6. Results and description of top-ranked genes with negative test statistic Dn.
NPCPS Ranking Dn CP Position Gene Name Description
5336 23.08 27 AGER Serum sRAGE levels were influenced by genetic polymorphisms
(2429 T/C, Gly82Ser and 2184 A/G) of the RAGE gene in breast
cancer
1929 22.91 27 GP1BB
5918 22.87 27
2064 22.87 27 MAPK14 The expression of p-p38 and uPA was negatively correlated to
prognosis of breast cancer.
4931 22.73 26 SLC5A5 The findings of this study indicated that NIS expression is prevalent
in breast cancer brain metastases and could have a therapeutic
role via the delivery of radioactive iodide and selective ablation of
tumor cells
4634 22.72 27 BMP1
2124 22.71 27
5753 22.69 27 MYOG
5907 22.62 32 MMP11 MMP-11 and CK-20 are probable prognostic markers whose
expression reflects the stages of tumor differentiation and LNM of
breast cancer
853 22.60 43 NCSTN NCSTN coded protein is a subunit of c-Secretase compound, which
is related to Notch signaling, a pathway found dysregulated in
many cancers.
4869 22.54 30 SLC4A2
5060 22.53 25 NAT6
4128 22.53 27 ALDH4A1
4516 22.52 21 SNAPC1
2257 22.51 27 WRN The variant genotype of WRN Leu1074Phe was associated with a
1.36-fold significantly increased risk of breast cancer in Chinese
women. This variant is also significantly associated with age at
menarche
6187 22.51 27 ENG Elevated pretreatment plasma endoglin levels predicted for
decreased clinical benefit and a shorter overall survival in
metastatic breast cancer patients treated with 2nd-line hormone
therapy.
2183 22.51 27 TRADD TRADD is involved in the p75(NTR)-mediated antiapoptotic activity
of nerve growth factor in breast cancer cells
4444 22.51 27 UNC119
doi:10.1371/journal.pone.0020060.t006
DGE Detecting Method Based on Change-Point
PLoS ONE | www.plosone.org 9 May 2011 | Volume 6 | Issue 5 | e20060non-parametric methods, LRS and PPST, had inferior results
when working with skew-normal data.
The AUC of ROC is summarized in Table 3 and 4.
DGE detection in breast-cancer microarray data
The microarray data used in the experiment are provided by
West [22]. In their experiment, primary breast tumors (between
1.5 and 5 cm in maximal dimension) from the Duke Breast
Cancer SPORE frozen tissue bank were selected and diagnosed as
invasive ductal carcinoma. In each case, a diagnostic axillary
lymph node dissection was performed. The final dataset includes
49 samples, 25 samples of which have negative lymph nodes and
24 samples with positive lymph nodes, used here as normal sample
and cancer sample, respectively. Gene expression profile of 7129
genes was obtained through annotation package hu6800 [23]. The
original gene expression values ranged from 34 to 43053 and were
initialized to the range from 3.5 to 10.7. Seven detection method
(t-statistic, COPA, OS, ORT, MOST, PPST and LRS) were
applied to the initialized gene expression profile, while NPCPS
was applied to the original data. The calculated test statistics of
these 7129 genes by these methods were sorted in descending
order.
For NPCPS, C(0.05)=1.628 was selected, which yields a
detecting result of 1978 DGE genes. Fig. 5 shows the distribution
of the estimated position of change-points in the expression value
of these genes. We selected the first 30 genes ranked by NPCPS,
and searched PubMed and other databases to confirm that
whether these genes were relevant to breast cancer or other known
cancers. Out of the first 30 genes identified by NPCPS, 17 have
been reported as relevant to breast cancer or other cancers (as
shown in Table 5 and Table 6 separately according to Dn value).
The gene expression values and the change-point (CP) positions of
the cancer-relevant genes are illustrated in Fig. 6 and Fig. 7. From
Fig. 6 and 7, it could be seen that the estimated change-point
positions could successfully locate the change in the trend of the
gene expression value.
Figure 6. Expression value and Change-point of top-ranked DGE genes with positive Dn. (A) PDE4B, change-point at sample 27. (B) C9,
change-point at sample 27. (C) ITK, change-point at sample 27. (D) TCF3, change-point at sample 41. (E) JAG1, change-point at sample 31. (F) HMGA2,
change-point at sample 16. (G) RARRES1, change-point at sample 26. (H) PRKCB, change-point at sample 15. CP position correctly locates the change
in the trend of the gene expression value.
doi:10.1371/journal.pone.0020060.g006
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MAPK14, change-point at sample 27. (C) SLC5A5, change-point at sample 26. (D) MMP11, change-point at sample 32. (E) NCSTN, change-point at
sample 43. (F) WRN, change-point at sample 27. (G) ENG, change-point at sample 27. (H) TRADD, change-point at sample 27. CP position correctly
locates the change in the trend of the gene expression value.
doi:10.1371/journal.pone.0020060.g007
Table 7. Ranking relevance between each DGE detecting methods.
NPCPS LRS COPA OS ORT PPST T MOST
NPCPS 1 0.0354 20.0346 0.0069 20.0311 20.0357 20.0398 20.0470
LRS 0.0354 1 0.5007 0.5274 0.3206 0.4182 0.4964 0.4474
COPA 20.0346 0.5007 1 0.5339 0.5175 0.5825 0.5140 0.5752
OS 0.0069 0.5274 0.5339 1 0.4443 0.5407 0.5868 0.4539
ORT 20.0311 0.3206 0.5175 0.4443 1 0.7921 0.2032 0.3069
PPST 20.0357 0.4182 0.5825 0.5407 0.7921 1 0.3645 0.4378
T 20.0398 0.4964 0.5140 0.5868 0.2032 0.3645 1 0.8394
MOST 20.0470 0.4474 0.5752 0.4539 0.3069 0.4378 0.8394 1
doi:10.1371/journal.pone.0020060.t007
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methods based on the test statistic, it was noticed that genes top-
ranked by NPCPS were ranked considerably lower by other
methods, most of which were mean and median based parametric
methods. When inspecting all the 7129 genes, the overall trend in
ranking difference between NPCPS and other methods became
more obvious. Table 7 shows the pair-wiselinearcorrelation of gene
ranking among the six methods. For NPCPS, the positive
correlation is below 0.007 with OS, and the negative correlation
below 0.047 with other methods. This indicated that NPCPS had
much less correlation with the other five methods, among which the
correlationswereallpositiveandvaluedaround0.5witheachother.
Figure 8. ROC curves of NPCPS and other methods when inappropriate formula applied. (A) Over expression formula applied to
simulated under expressed gene, n1=n2=25, m=22, k=8. (B) Under expression formula applied to simulated over expressed gene, n1=n2=25,
m=2,k=8. The x-axis is FPR, and the y-axis is TPR. h is T,6is COPA, # is OS, N is ORT, e is MOST, dotted line is LRS, dashed line is PPST, and solid line
is NPCPS. The significance level a=0.01 for NPCPS. NPCPS maintained the same level of sensitivity when applied to both types of simulated over-
expressions. The other methods were not able to give results as good as when appropriate functions were applied as in Fig. 2 and Fig. 3.
doi:10.1371/journal.pone.0020060.g008
Figure 9. Data distributions of genes top-ranked by NPCPS. (A) I1GAP1: rank 19, positive Dn. (B) PIP5K1B: rank 20, positive Dn. (C) UBB: rank
21, negative Dn. (D) RFC1: rank 22, negative Dn. Top-ranked genes by NPCPS had significant difference between the data distributions of cancer and
normal groups. By comparing the empirical distribution of cancer and normal samples, (A) and (B) had distributions of cancer group that were
significantly left to the distribution of normal group, which demonstrated under-expression; (C) and (D) had distributions of cancer group that were
significantly right to the distribution of normal group, which demonstrated over expression. The distribution curves were consistent with the
biological significance of Dn value.
doi:10.1371/journal.pone.0020060.g009
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combined with other methods, it would help to identify genes which
are considered as less DGE significant by the other seven methods.
Discussions on the biological significance of NPCPS
Non-parametric statistics. As a non-parametric statistics,
NPCPS does not rely on assumptions that the data are drawn from
a given probability distribution. It is applicable to input data
derived from various types distributions and doesn’t require data
pre-processing. As such it is the opposite of parametric statistics,
which would have inferior performance when the input data are
not in the assumed distribution, as in the ROC simulation on
normal and skew-normal datasets (Fig. 4).
No restriction on both over expression and under expres-
sion. The gene expression profile generated from microarray
data usually contains samples of thousands of genes. Genes in the
cancer samples might be over or under expressed. Majority of
the DGE detecting methods have different formulas for under
expressed and over expressed genes, respectively. For example, OS
and ORT use different percentile values for over-expression and
under-expression, respectively, and apply both formulas to the
same microarray data. If over expression formula is applied to
under expressed data, the DGE can not be correctly recognized.
However, the detected results might contains false alarms, since
both over-expression and under-expression formulas are applied
to the same gene, and might be detected as DGE significant
Figure 10. Data distribution of genes bottom-ranked by NPCPS. (A) SLC6A8: rank 500. (B) HLF: rank 1000. (C) ATP5F1: rank 2000. (D) HLA-H:
rank 3000. (E) ODF3B: rank 4000. (F) SLC20A2: rank 5000. (G) SGSH: rank 6000. (H) CXCR2: rank 7000. From the empirical data distribution, the
differences between cancer and normal groups in (A)–(D) were very small, which corresponded with the Dn value.
doi:10.1371/journal.pone.0020060.g010
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of DGE by using the same calculating formula, which would
reduce the FDR, and do not require further analysis and
computation aiming to clean the false alarms. When over
expression formula was applied to under-expressed gene data
(Fig. 8A), and vice versa (Fig. 8B), NPCPS presented stable perf-
ormance in both situations, while other compared methods gave
inferior ROC curves. According to the characteristic of ROC, T
and MOST could have good ROC if the prediction result was
inversed. The ROC curves of LRS were in the zone of random
guess, which was close to the line-of-no-discrimination. Using LRS
for under-expresson, user could turn under-expression into over-
expression by inversing the dataset. This indicated that when
over-expression formula of LRS was applied to under-expression,
the random detecting result would be given.
Estimated change point position: ^ t t0
The biological meaning of ^ t t0 lies in that once the position
of change point is estimated or located, we can identify which
samplecontainsDGE.Then,ratherthan identifyingDGE existence
in n=n1+n2 samples on the single gene level, we can learn that, for
one sample containing thousands of genes, how many genes were
over expressed or under expressed. This statistical information can
be used to analyze features of each sample, and the results of which
could be applied to the estimation of the differentiation degree of
cancer in different development stages.
Figure 11. Data distributions of genes top-ranked by five parametric methods. (A) Gene TFF1, COPA rank: 8, NPCPS rank: 5281. (B) Gene
ERBB2, COPA rank: 18, NPCPS rank: 6256. (C) Gene ZNF44, OS rank: 6, NPCPS rank: 7057. (D) Gene RGS2, OS rank: 24, NPCPS rank: 6222. (E) Gene TCN1,
ORT rank: 7, NPCPS rank: 7113. (F) Gene TRAPPC10, ORT rank: 9, NPCPS rank: 6732. (G) Gene CLDN10, T rank: 22, NPCPS rank: 1107. (H) Gene CSNK1E,
T rank: 24, NPCPS rank: 1163. (I) Gene COL2A1, MOST rank: 10, NPCPS rank: 7126. (J) Gene SCG2, MOST rank: 10, NPCPS rank: 2585. Top-ranked genes
by the five parametric methods did not have significant difference between the data distributions of cancer and normal groups.
doi:10.1371/journal.pone.0020060.g011
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NPCPS results showed that, among the 7219 genes, 3608 had
negative Dn, while the rest 3521 had positive Dn. NPCPS use Dn
to evaluate the change in distribution between normal and cancer
samples, and directly measure the DGE type as either over
expressed or under expressed. This feature is valid based on the
expression value in Fig. 6 and 7, where Fig. 6 (positive Dn) shows
typical under expression and Fig. 7 (negative Dn) shows typical
over expression. Fig. 9 and Fig. 10 can illustrate the relationship
between Dn and DGE in a more intuitive manner where
cumulative data distributions of several typically ranked genes
are given.
Genes in Fig.9 were ranked on the top by NPCPS,where Fig.9A
and 9B are corresponding to positive Dn (under-expression), 9C and
9D are corresponding to negative Dn (over-expression), respectively.
By comparing the empirical distribution of cancer and normal
samples, in Fig. 9A and 9B, cancer group was significantly left to the
normal group, which demonstrated under expression; in Fig. 9C
and 9D, the cancer group was significantly right to the normal
group, whichdemonstrated over-expression.The distributiongraph
was consistent with the Dn value.
Genes in Fig. 10 were ranked lower by NPCPS. We can find
that the cumulative distance between the data distributions of
normal and cancer group is generally smaller compared with those
genes top-ranked by NPCPS. From the empirical data distribu-
tion, difference between cancer and normal groups were very
small.
As comparison, Fig. 11A–11J shows the data distributions of
those top-ranked genes by the parametric methods, and Fig. 12A–
12D by LRS and PPST. The data distributions were more similar
to genes that were bottom-ranked by NPCPS in that small percent
of the samples bring significant increase to data range. These few
samples would greatly impact the cancer-group mean or median,
which consequently result in a high test statistic of parametric
methods. For example, in Fig. 11B and 12B, 96% of the two
curves were close to each other while 4% data points in the normal
group valued much greater, which equals to one outlier sample out
of the 25 normal samples. Considering that the outliers were in the
normal group, it was reasonable to assume that these outliers
might be caused by microarray noise. For the rest of Fig. 11 and
12, except for T-statistic, the cancer group had one outlier. Fig. 11
and 12 indicate that the comparing methods are sensitive to
significant change in mean and median, even when the change is
introduced by a single sample which might be outliers. NPCPS is
less prone to report a DGE as such few outliers are not sufficient to
produce a large Dn.
In summary, NPCPS is less sensitive to right boundaries and
tends to find genes that have greater cumulative distance between
the data distribution of normal and cancer groups. For such genes,
the samples in normal and cancer group may have the same data
range but should have very different distributions. Therefore,
the detecting result of NPCPS would be different from other
compared methods, which are more sensitive to outliers that
influence the data range, rather than the cumulative distance
between distributions. In other words, NPCPS values continuous
change in data distribution over the whole data range, while the
other methods look for a significant change of mean or median.
This would explain the low correlation between NPCPS and other
methods.
Conclusion
A non-parametric statistical method, NPCPS, was proposed for
DGE detection based on change-point theory. NPCPS uses the
data distribution of normal and cancer samples as the only input to
detect a change point that indicates DGE, in order to identify
potential cancer genes. Distribution-based NPCPS does not
require data pre-initialization and is computationally efficient
compared with other median-based parametric methods. Contrast
Figure 12. Data distributions of genes top-ranked by two non-parametric methods. (A) Gene MGP, LRS rank: 11, NPCPS rank: 7049. (B)
Gene IGF2, LRS rank: 21, NPCPS rank: 7094. (C) Gene TNNC1, PPST rank: 21, NPCPS rank: 3697. (D) Gene E4F1, PPST rank: 47, NPCPS rank: 2595. Top-
ranked genes by the two non-parametric methods did not have significant difference between the data distributions of cancer and normal groups.
doi:10.1371/journal.pone.0020060.g012
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and under-expression by the same equation. Another unique
feature is that the proposed NPCPS could estimate both the
number and the location of cancer samples with DGE could
be estimated. Simulation study and experiments showed that, the
proposed NPCPS method had better reliability and accuracy;
NPCPS was more effective than the compared parametric
methods; similar ROC curves was given compared with LRS
when sample size was larger; when the simulated DGE value
was smaller, i.e. DGE was less significant, NPCPS had better
sensitivity compared with the other seven methods. Simulations
also indicated that, for cancer subgroup with size greater than 8,
the NPCPS had FPR less than 0.01. Besides, the detection results
of NPCPS had very low correlation with the compared methods,
both parametric and non-parametric, which indicates that NPCPS
provides meaningful detection results different from other
methods. Since cancer samples could be categorized according
to different stages in the cancer development, DGE detection can
also be considered also a multi-class problem. Further effort could
be focused on the multi-change-point in the distribution of
microarray gene expression profile.
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